http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110642952-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110642952-B |
| titleOfInvention | anti-HER 3 antibody, preparation method and application thereof |
| abstract | The invention provides an anti-HER 3 antibody, a preparation method and application thereof. Specifically, the invention provides a novel anti-HER 3 antibody, which has strong affinity with HER3 molecules and can be specifically combined with antigen molecules, particularly a human-mouse chimeric antibody, so that the immunogenicity of a mouse antibody is effectively reduced. The HER3 antibody is combined with cetuximab, so that the activity of the cetuximab can be obviously enhanced, and the dosage of the cetuximab can be reduced. |
| priorityDate | 2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 883.